Search clinical trials for: Dysmorphoses
Total 2 results
-
University Hospital, Strasbourg, FranceRecruitingMaxillofacial AbnormalitiesFrance
-
Cliniques universitaires Saint-Luc- Université...Unknown
Sponsors and Collaborators
- Department of Orthopedics, Norrköping
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Diabetes Research Institute, Munich, Germany.
- Canadian Glycomics Network (GlycoNet)
- Merve Şeker
- EXCELYA Bordeaux
- Alcohol Education and rehabilitation Fund
- Rivus Pharmaceuticals, Inc.
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Pearl Network
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- kıvan çevik kaya
- Jinxiang County People's Hospital
- Retina Foundation of Canada
- South Texas Health System McAllen
- Critical Care Pharmacotherapy Trials Network
- Dr. Khaled Ahmed Yassen
- Bettina Eiger
- Phoenix VA Health Care System
- EndoTheia
- View Full List
Medical Conditions
- Dystonic Disorders
- Myocardial Haemorrhage
- Acute Rotator Cuff Tear Related to Trauma
- Malignant Pelvic Neoplasm
- Encephalitis, Arbovirus
- Morton's Neuroma
- Secondary Pulmonary Arterial Hypertension
- Fluorescein Angiography
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Cystic Renal Disease
- Poststroke Fatigue
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Deep Neck Space Infections
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- Presence / Absence of EBV
- Newborn Infants
- Tumor Cell, Circulating
- Racial Bias
- Ruptured Achilles Tendon
- View Full List
Drug Interventions
- Anastrozole
- Tranexamic acid
- Vinorelbine tartrate
- Tenofovir
- Cetuximab
- Visanne (Dienogest, BAY86-5258)
- Ketamine 0.3 mg/kg at anesthesia induction
- PCO371
- Nicoderm C-Q Transdermal Product
- Granulocyte colony-stimulating factor
- Sodium Nitroprusside
- 30 mg CVL-231 as slow-release MR formulation
- Sipuleucel-T
- 6-Mercaptopurine
- Amisulpride Oral Tablet
- Percutaneous sirolimus
- Follitropin beta liquid formulation
- 5.0g SRT501
- Trastuzumab in combination with SubQ GM-CSF
- Modified Bolus 5-FU/LV with Irinotecan
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Angola
- Contract Research Organizations in Australia
- Contract Research Organizations in Colombia
- Contract Research Organizations in Guinea
- Contract Research Organizations in Hungary
- Contract Research Organizations in Kosovo
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Portugal
- Contract Research Organizations in Romania
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Zimbabwe
- CRO list by country